Anindita Chakrabarty

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 14, 2026
Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.

|Nov 20, 2025
Mapping the Progression of Therapy-Induced Senescence to Therapy Tolerance: An Evolutionarily Conserved Mechanism for Optimizing Cancer Treatment with Senotherapeutics.

Gargi Mukherjee, Neha Dutta, Muthumeena Ramanathan

|May 16, 2024
Opposing Interplay between Nuclear Factor Erythroid 2-Related Factor 2 and Forkhead BoxO 1/3 is Responsible for Sepantronium Bromide's Poor Efficacy and Resistance in Cancer cells: Opportunity for Combination Therapy in Triple Negative Breast Cancer.

Shaista Haider, Shayantani Chakraborty, Goutam Chowdhury

|Sep 13, 2022
The Natural Products Withaferin A and Withanone from the Medicinal Herb Withania somnifera Are Covalent Inhibitors of the SARS-CoV-2 Main Protease.

Shayantani Chakraborty, Dibyendu Mallick, Mausumi Goswami

|May 28, 2021
Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155).

Tasaduq Hussain Wani, Goutam Chowdhury, Anindita Chakrabarty

Pageof 1

Frequent Collaborators

4 joint publications

Goutam Chowdhury

2 joint publications

Shaista Haider

1 joint publications

Mausumi Goswami

1 joint publications

F Peter Guengerich